位置:首页 > 产品库 > 重组可溶性半乳糖凝集素3结合蛋白
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
重组可溶性半乳糖凝集素3结合蛋白
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。

重组可溶性半乳糖凝集素3结合蛋白(LGALS3BP)
Recombinant LGALS3BP
基因名:

LGALS3BP


产品别名:

90K; BTBD17B; CyCAP; M2BP; MAC-2-BP; TANGO10B; gp90; LGALS3BP; galectin 3 binding protein; galectin 3 binding protein; galectin-3-binding protein; L3 antigen; MAC2BP; Mac-2-binding protein; basement membrane autoantigen p105; lectin galactoside-binding soluble 3-binding protein; mac-2 BP; serum protein 90K; transport and golgi organization 10 homolog B; tumor-associated antigen 90K; 可溶性半乳糖凝集素3结合蛋白; 可溶性半乳糖凝集素3结合蛋白(LGALS3BP);


背景信息:
LGALS3BP is a ligand of galectin 3, and has been suggested to influence tumor proliferation and metastasis formation. Galectins and their ligands have been implicated in cell transformation and cancer metastasis, and found to have prognostic value. LGALS3BP also known as Mac 2 BP,and as 90K, is a highly glycosylated, secreted protein extensively studied in human cancer, which binds galectin 1, galectin 3 and galectin 7. High expression levels of this molecule are associated with a shorter survival, the occurrence of metastasis or a reduced response to chemotherapy in patients with different types of malignancy. The mechanisms underlying the prognostic significance of 90K and galectins in cancer are far from being understood, although they may be related to the ability of these proteins to interact and, to some extent, modulate cell cell and cell matrix adhesion and apoptosis.
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025